Evidence map›Paper›PMID 19886838›Full record

Trial reportAIDS research and human retroviruses2009

Immunologic markers as predictors of tuberculosis-associated immune reconstitution inflammatory syndrome in HIV and tuberculosis coinfected persons in Thailand.

Hong Van Tieu, Jintanat Ananworanich, Anchalee Avihingsanon, Wichitra Apateerapong, Sunee Sirivichayakul, Umaporn Siangphoe, Sukonsri Klongugkara, Benjawan Boonchokchai, Scott M Hammer, Weerawat Manosuthi

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in AIDS research and human retroviruses, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Phenotypic Profile ofOpen forum infectious diseases · 2023
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. HIV and co-infections.Immunological reviews · 2013
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Hong Van TieuDepartment of Medicine, Division of Infectious Diseases, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA. hvt2106@columbia.edu
Jintanat Ananworanich
Anchalee Avihingsanon
Wichitra Apateerapong
Sunee Sirivichayakul
Umaporn Siangphoe
Sukonsri Klongugkara
Benjawan Boonchokchai
Scott M Hammer
Weerawat Manosuthi
Bamrasnaradura Infectious Diseases Institute · THColumbia University · USChulalongkorn University · THHIV Netherlands Australia Thailand Research Collaboration · THThai Red Cross Society · TH

Funding

Training in the Epidemiology of Infectious DiseasesT32AI049821 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI EL-SADR, WAFAA M. · 2001 to 2010
$2.5M
NIAID NIH HHS T32 AI049821-07
6 · The paper itself

Abstract

This study analyzes immunologic markers to predict and diagnose tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) in HIV and TB coinfected adults who initiated antiretroviral therapy (ART) in Thailand. T helper 1 cytokines interleukin (IL)-2, IL-12, and interferon-gamma (IFN-gamma) levels in response to PPD and RD1 antigens were assessed prior to ART, at weeks 6, 12, and 24 of treatment, and at time of TB-IRIS. Of 126 subjects, 22 (17.5%) developed TB-IRIS; 14 (64%) subjects received steroid treatment and 3 (14%) received NSAIDs; none of the subjects died. Median interval between ART initiation and TB-IRIS development was 14 days. IFN-gamma, IL-2, and IL-12 responses did not differ between TB-IRIS and no TB-IRIS subjects (p > 0.05). More research into the immunopathogenesis of TB-IRIS and diagnostic potential of cytokine markers is warranted.

Indexed as

AIDS-Related Opportunistic InfectionsHIV InfectionsImmune Reconstitution Inflammatory SyndromeTuberculosisAdultAntiretroviral Therapy, Highly ActiveAntitubercular AgentsBiomarkersCytokinesFemaleHumansMalePredictive Value of TestsTh1 CellsThailandTreatment OutcomeAntitubercular AgentsBiomarkersCytokines

Identifiers

PMID19886838
PMCPMC2828258
OpenAlexW2044289886

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.